A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Clinical trial NCT07061288 · RECRUITING
Trial details
- NCT number
- NCT07061288
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-03
- Primary completion
- 2027-06-21
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.